StockData
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. (ORMP) stock

ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.69−0.20 (-5.14%)

Close on Nov 19, 2026Market cap $153.49MP/E 0.9Yield 6.78%

Oramed Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Oramed Pharmaceuticals's gross profit for the twelve months ending Dec 31, 2025 was $13.00K. For fiscal 2025 it was $13.00K, down 99.5% from the year before. The highest annual figure on record is $2.61M in fiscal 2019.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.00K-99.5%
FY2019Aug 31, 2019$2.61M+3.1%
FY2018Aug 31, 2018$2.54M+11.7%
FY2017Aug 31, 2017$2.27M+1402.6%
FY2016Aug 31, 2016$151.00K–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ4 2025Dec 31, 2025$0-100.0%
Q3 FY2025CQ3 2025Sep 30, 2025$0-100.0%
Q2 FY2025CQ2 2025Jun 30, 2025$0-100.0%
Q1 FY2025CQ1 2025Mar 31, 2025$13.00K-98.2%
Q4 FY2019CQ3 2019Aug 31, 2019$681.00K+10.2%
Q3 FY2019CQ2 2019May 31, 2019$682.00K+10.5%
Q4 FY2018CQ3 2018Aug 31, 2018$617.00K+1.0%
Q3 FY2018CQ2 2018May 31, 2018$703.00K+66.2%
Q4 FY2017CQ3 2017Aug 31, 2017$618.00K+44.7%
Q3 FY2017CQ2 2017May 31, 2017$617.00K–
Q2 FY2017CQ1 2017Feb 28, 2017$611.00K+405.0%
Q1 FY2017CQ4 2016Nov 30, 2016$423.00K–
Q4 FY2016CQ3 2016Aug 31, 2016$427.00K–
Q3 FY2016CQ2 2016May 31, 2016-$155.00K–
Q2 FY2016CQ1 2016Feb 29, 2016$121.00K–

More Oramed Pharmaceuticals figures

See a number that looks wrong?